Race
Visit Number vs Inhibition Total Error Scaled Score
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Baseline | 432 | 7.6 | ± 3.9 | 8.0 | 1.0 | 16.0 | 21 | 453 |
Follow-up | 393 | 8.3 | ± 3.9 | 9.0 | 1.0 | 18.0 | 60 | 453 |
Treatment Arm vs Inhibition Total Error Scaled Score
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 432 | 7.6 | ± 3.9 | 8.0 | 1.0 | 16.0 | 21 | 453 |
Early adenotonsillectomy | 214 | 7.5 | ± 4.0 | 8.0 | 1.0 | 16.0 | 12 | 226 |
Watchful waiting | 218 | 7.7 | ± 3.8 | 8.0 | 1.0 | 16.0 | 9 | 227 |
Treatment Arm vs Inhibition Total Error Scaled Score
Follow-up
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 393 | 8.3 | ± 3.9 | 9.0 | 1.0 | 18.0 | 60 | 453 |
Early adenotonsillectomy | 195 | 8.6 | ± 4.1 | 9.0 | 1.0 | 18.0 | 31 | 226 |
Watchful waiting | 198 | 8.0 | ± 3.7 | 8.0 | 1.0 | 17.0 | 29 | 227 |
Age vs Inhibition Total Error Scaled Score
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 432 | 7.6 | ± 3.9 | 8.0 | 1.0 | 16.0 | 21 | 453 |
5-7 yrs old | 311 | 7.6 | ± 4.0 | 8.0 | 1.0 | 16.0 | 18 | 329 |
8-10 yrs old | 121 | 7.6 | ± 3.7 | 8.0 | 1.0 | 15.0 | 3 | 124 |
Age vs Inhibition Total Error Scaled Score
Follow-up
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 392 | 8.3 | ± 3.9 | 9.0 | 1.0 | 18.0 | 7 | 399 |
5-7 yrs old | 257 | 8.3 | ± 4.1 | 9.0 | 1.0 | 18.0 | 5 | 262 |
8-10 yrs old | 135 | 8.3 | ± 3.6 | 8.0 | 1.0 | 17.0 | 2 | 137 |
Gender vs Inhibition Total Error Scaled Score
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 432 | 7.6 | ± 3.9 | 8.0 | 1.0 | 16.0 | 21 | 453 |
Female | 225 | 8.0 | ± 4.1 | 8.0 | 1.0 | 16.0 | 9 | 234 |
Male | 207 | 7.2 | ± 3.6 | 8.0 | 1.0 | 15.0 | 12 | 219 |
Gender vs Inhibition Total Error Scaled Score
Follow-up
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 393 | 8.3 | ± 3.9 | 9.0 | 1.0 | 18.0 | 60 | 453 |
Female | 200 | 8.9 | ± 4.0 | 9.0 | 1.0 | 18.0 | 34 | 234 |
Male | 193 | 7.7 | ± 3.7 | 8.0 | 1.0 | 16.0 | 26 | 219 |
Race vs Inhibition Total Error Scaled Score
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 432 | 7.6 | ± 3.9 | 8.0 | 1.0 | 16.0 | 21 | 453 |
White | 153 | 9.1 | ± 3.4 | 9.0 | 1.0 | 16.0 | 3 | 156 |
Black | 233 | 6.7 | ± 3.8 | 7.0 | 1.0 | 15.0 | 16 | 249 |
Other | 46 | 6.9 | ± 4.5 | 7.0 | 1.0 | 16.0 | 2 | 48 |
Race vs Inhibition Total Error Scaled Score
Follow-up
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 393 | 8.3 | ± 3.9 | 9.0 | 1.0 | 18.0 | 60 | 453 |
White | 145 | 9.8 | ± 3.6 | 10.0 | 1.0 | 18.0 | 11 | 156 |
Black | 206 | 7.3 | ± 3.8 | 7.0 | 1.0 | 16.0 | 43 | 249 |
Other | 42 | 8.3 | ± 4.1 | 8.0 | 1.0 | 17.0 | 6 | 48 |